Xenon Pharmaceuticals
Daniel Lee is a highly experienced professional in the field of psychiatry and clinical development, currently serving as Clinical Development Team Lead - Senior Medical Director at Xenon Pharmaceuticals Inc. since November 2023. With a comprehensive background that includes roles as an Independent Consultant and Expert Witness at Psychopharmacology & Regulatory Consulting, Inc. and Clinical Development Team Lead at Otsuka Pharmaceutical Companies (U.S.), Daniel Lee specializes in trial design, biopharmacologic product development, and complex psychiatric disorders. Previous experience as a Medical Officer at the FDA informs a deep understanding of regulatory processes for CNS drugs. Daniel Lee holds a Doctor of Medicine degree from Uniformed Services University and completed psychiatric residency at Walter Reed National Military Medical Center.
This person is not in any teams
This person is not in any offices
Xenon Pharmaceuticals
1 followers
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders.